3,4-DAA is an orally active Anthranilic acid derivative with potent immunosuppressive activities. 3, 4-DAA can alleviate the severity of colitis through inhibiting Th1 cells response, promoting Th2 cytokines expression and inducing CD4+CD25+ T cells expression[1]. 3,4-DAA suppressed expression of inducible nitric oxide synthase (iNOS) and nitric oxide (NO) release from EOC20 cells induced by IFN-gamma and Lipopolysaccharide[2].
Molecular Weight:
343.33
CAS Number:
[2117759-07-4]
Formula:
C18H17NO6
Target:
NO Synthase
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
